Niloufar Javanmardi

Emergence of New <i>ALK</i> Mutations at Relapse of Neuroblastoma

Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard et al. · Journal of Clinical Oncology · 2014 · 211 citations

Medicine, Genetics, Oncology +17

Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma

Agnes Rasmuson, Lova Segerström, Maria Nethander et al. · PLoS ONE · 2012 · 53 citations · Full text

Medicine, Genetics, Oncology +13

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

Joachim T. Siaw, Niloufar Javanmardi, Jimmy Van den Eynden et al. · Cell Reports · 2020 · 53 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Intragenic anaplastic lymphoma kinase (<i>ALK</i>) rearrangements: Translocations as a novel mechanism of <i>ALK</i> activation in neuroblastoma tumors

Susanne Fransson, Magnus Hansson, Kristina Ruuth et al. · Genes Chromosomes and Cancer · 2014 · 52 citations · Full text

Medicine, Molecular Genetics, Oncology +17

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas

Ganesh Umapathy, Jikui Guan, Dan Gustafsson et al. · Science Signaling · 2017 · 52 citations

Medicine, Oncology, Pharmacology +16